Secretome Therapeutics is a clinical-stage biotechnology company developing novel cellular therapies derived from neonatal cardiac progenitor cells (nCPC).

The company's lead product candidate, STM-01, is a cellular therapy designed to modulate inflammatory and fibrotic pathways and support myocardial function in patients with Duchenne Muscular Dystrophy (DMD) and Heart Failure with Preserved Ejection Fraction (HFpEF).

Secretome is also advancing STM-21, a secretome-based therapeutic in preclinical development, along with other nCPC-based products. The company is focused on addressing serious cardiovascular and muscular conditions through innovative regenerative medicine approaches.

Headquarters: Plano, Texas

Work at Secretome Therapeutics?

Post a role here — reach candidates already searching for your company.

Open roles (1)

Matching roles

Director of Data Management

Candidate hiring reports